A computational approach based on a multiaxial fatigue criterion combining phase transformation and shakedown response for the fatigue life assessment of Nitinol stents
Source abstract
Abstract
Self-expanding stents made of Nitinol, a Nickel–Titanium shape memory alloy, are used in standard medical implants for the treatment of cardiovascular diseases. Despite the increasing success, clinical studies have reported stent failure after the deployment in the human body, thus undermining patient’s safety and life. This study aims to fill the gap of reliable assessment of the fatigue life of Nitinol stents. We propose a global computational design method for preclinical validation of Nitinol stents, which can be extended to patient-specific computations. The proposed methodology is composed of a mechanical finite element analysis and a fatigue analysis. The latter analysis is based on a novel multiaxial fatigue criterion of the Dang Van type, combining the shakedown response of the stent and the complexity of phase transformation taking place within the material. The method is implemented in the case of a carotid artery stent. The implant configuration as well as the applied cyclic loading are shown to affect material phase evolution as well as stent lifetime. The comparison with the results obtained by applying a strain-based constant-life diagram approach allows to critically discuss both fatigue criteria and to provide useful recommendations about their applicability.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Shape Memory Alloy Transformations · Ultrasonics and Acoustic Wave Propagation · Elasticity and Material Modeling
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Dipartimento di Ingegneria Civile e Architettura, Università di Pavia, Pavia, Italy
Dipartimento di Strutture per l’Ingegneria e l’Architettura, Università di Napoli Federico II, Napoli, Italy
Laboratoire de Mécanique des Solides, CNRS, École Polytechnique, Palaiseau Cedex, France
References (42)
Show source-provided references
1. 10.1080/10255842.2012.71362510.1080/10255842.2012.713625 ↗
2. 10.1016/j.ijfatigue.2016.10.00510.1016/j.ijfatigue.2016.10.005 ↗
3. 10.1007/s40830-018-0150-710.1007/s40830-018-0150-7 ↗
4. 10.1016/j.ijfatigue.2014.04.01310.1016/j.ijfatigue.2014.04.013 ↗
5. 10.1007/s10439-015-1447-810.1007/s10439-015-1447-8 ↗
6. 10.1016/j.ijfatigue.2016.01.01710.1016/j.ijfatigue.2016.01.017 ↗
7. Auricchio F · Computer Modeling in Engineering and Sciences · 2010 · 57 · 225
8. 10.1016/j.tafmec.2017.04.00110.1016/j.tafmec.2017.04.001 ↗
9. 10.1016/j.jvs.2011.03.25710.1016/j.jvs.2011.03.257 ↗
10. 10.1016/j.medengphy.2014.03.00610.1016/j.medengphy.2014.03.006 ↗
11. 10.1007/s10439-015-1476-310.1007/s10439-015-1476-3 ↗
12. 10.1016/j.ijplas.2006.04.00110.1016/j.ijplas.2006.04.001 ↗
13. 10.1007/s00270-011-0149-310.1007/s00270-011-0149-3 ↗
14. 10.1016/j.jcin.2011.04.00910.1016/j.jcin.2011.04.009 ↗
15. 10.1016/j.jcin.2010.07.01610.1016/j.jcin.2010.07.016 ↗
16. 10.1088/0964-1726/25/11/11501210.1088/0964-1726/25/11/115012 ↗
17. 10.1177/1045389X1773092310.1177/1045389X17730923 ↗
18. ISO 25539-2:2012 (2012) Cardiovascular implants—endovascular devices—part 2: vascular stents.
19. 10.1016/j.jmbbm.2012.11.00610.1016/j.jmbbm.2012.11.006 ↗
20. 10.1016/j.cad.2013.05.00310.1016/j.cad.2013.05.003 ↗
21. 10.1016/j.jbiomech.2004.07.02210.1016/j.jbiomech.2004.07.022 ↗
22. 10.1177/1045389X950060061010.1177/1045389X9500600610 ↗
23. 10.1016/j.jmbbm.2015.06.01010.1016/j.jmbbm.2015.06.010 ↗
24. 10.1007/s11665-014-0965-010.1007/s11665-014-0965-0 ↗
25. 10.1583/10-3069.110.1583/10-3069.1 ↗
26. 10.1016/j.jvs.2008.02.02910.1016/j.jvs.2008.02.029 ↗
27. 10.1016/j.msea.2017.09.01610.1016/j.msea.2017.09.016 ↗
28. 10.1016/j.euromechsol.2010.03.01110.1016/j.euromechsol.2010.03.011 ↗
29. 10.1007/s11665-011-9864-910.1007/s11665-011-9864-9 ↗
30. 10.1016/j.jmbbm.2007.08.00110.1016/j.jmbbm.2007.08.001 ↗
31. 10.1007/s10439-015-1472-710.1007/s10439-015-1472-7 ↗
32. 10.1007/s40830-015-0020-510.1007/s40830-015-0020-5 ↗
33. 10.1179/1743280411Y.000000000910.1179/1743280411Y.0000000009 ↗
34. 10.1016/j.biomaterials.2011.03.05710.1016/j.biomaterials.2011.03.057 ↗
35. 10.1016/j.ijfatigue.2018.02.02810.1016/j.ijfatigue.2018.02.028 ↗
36. 10.1016/j.jvs.2010.01.05010.1016/j.jvs.2010.01.050 ↗
37. 10.1016/S0997-7538(98)80005-310.1016/S0997-7538(98)80005-3 ↗
38. U.S. Food and Drug Administration · 2010
39. 10.1016/j.jvs.2006.08.08610.1016/j.jvs.2006.08.086 ↗
40. 10.1177/1045389X1668544210.1177/1045389X16685442 ↗
41. 10.1016/j.ijfatigue.2016.08.02410.1016/j.ijfatigue.2016.08.024 ↗
42. 10.1016/j.ijplas.2016.12.00810.1016/j.ijplas.2016.12.008 ↗